<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04336917</url>
  </required_header>
  <id_info>
    <org_study_id>Breast Cancer-RISS</org_study_id>
    <nct_id>NCT04336917</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Rhomboid Intercostal and Subserratus Plane Block in Breast Cancer Surgeries</brief_title>
  <official_title>Ultrasound Guided Rhomboid Intercostal and Subserratus Plane Block in Breast Cancer Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konya Meram State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konya Meram State Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative analgesia after breast cancer surgery is a challenge for anesthesiologists due&#xD;
      to the complex innervation of the breast. Interfascial plane blocks of the chest are gaining&#xD;
      widespread popularity with the introduction of ultrasonography into the regional anesthesia&#xD;
      practice. We aimed to investigate the efficacy of Rhomboid intercostal and subserratus plane&#xD;
      block (RISS) for postoperative analgesia in patients undergoing breast cancer surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective randomized controlled trial will be carried out on female patients who&#xD;
      scheduled for breast cancer surgery. Our hypotesis is that this new interfascial plane block&#xD;
      technique will able to provide postoperative analgesia in breast cancer surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 31, 2020</start_date>
  <completion_date type="Actual">March 1, 2021</completion_date>
  <primary_completion_date type="Actual">February 5, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative opiod consumption</measure>
    <time_frame>The first 24 hours postoperatively</time_frame>
    <description>Opioid consumptions for both group will be recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain scores</measure>
    <time_frame>The first 24 hours postoperatively</time_frame>
    <description>Postoperative pain will be assessed using a Numeric Rating Scale (NRS) ranging from 0 (no pain) to 10 (worst imaginable pain).The NRS will be recorded in postoperative unit and in ward at first hour and at 2th, 6th, 12th and 24 th hour.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Breast Cancer Surgery</condition>
  <condition>Postoperative Analgesia</condition>
  <arm_group>
    <arm_group_label>Group Rhomboid Intercostal and Subserratus Plane Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In addition to routine standard perioperative and postoperative analgesic protocol participants will recieve Rhomboid Intercostal and Subserratus Plane Block under ultrasound guidence at the end of the surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Routine standard perioperative and postoperative analgesic protocol will be given.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rhomboid Intercostal and Subserratus Plane Block with local anesthetic</intervention_name>
    <description>Local anesthetic will be injected in the tissue planes between the rhomboid and the intercostal muscles and the serratus anterior and external intercostal muscles with ultrasound guidence.</description>
    <arm_group_label>Group Rhomboid Intercostal and Subserratus Plane Block</arm_group_label>
    <other_name>40 mL of bupivacaine/lidocaine mixture</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female patients aged 18-85 years and ASA physiological score I-III who undergone&#xD;
             breast cancer surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients refused to participate.&#xD;
&#xD;
          -  Patients with known or suspected allergy to the used medication.&#xD;
&#xD;
          -  Patients with psychiatric-neurological disorders that may affect pain perception,&#xD;
&#xD;
          -  Patients regularly taking antipsychotics and antidepressants.&#xD;
&#xD;
          -  Patients with potential risk of coagulopathy.&#xD;
&#xD;
          -  Uncooperative patients.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Betul Kozanhan, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>SBÃœ Konya EAH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Konya Education and Training Hospital</name>
      <address>
        <city>Konya</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 2, 2020</study_first_submitted>
  <study_first_submitted_qc>April 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2020</study_first_posted>
  <last_update_submitted>April 18, 2021</last_update_submitted>
  <last_update_submitted_qc>April 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konya Meram State Hospital</investigator_affiliation>
    <investigator_full_name>Betul Kozanhan</investigator_full_name>
    <investigator_title>Ass.Prof.</investigator_title>
  </responsible_party>
  <keyword>Rhomboid intercostal and subserratus plane block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

